343 related articles for article (PubMed ID: 19447208)
61. Engineering DNA scaffolds for delivery of anticancer therapeutics.
Sun W; Gu Z
Biomater Sci; 2015 Jul; 3(7):1018-24. PubMed ID: 26221936
[TBL] [Abstract][Full Text] [Related]
62. Nanostructured lipid carriers, solid lipid nanoparticles, and polymeric nanoparticles: which kind of drug delivery system is better for glioblastoma chemotherapy?
Qu J; Zhang L; Chen Z; Mao G; Gao Z; Lai X; Zhu X; Zhu J
Drug Deliv; 2016 Nov; 23(9):3408-3416. PubMed ID: 27181462
[TBL] [Abstract][Full Text] [Related]
63. The formalism of fractal aggregation phenomena of colloidal drug delivery systems.
Pippa N; Demetzos C; Danezis E
J Liposome Res; 2012 Mar; 22(1):55-61. PubMed ID: 21774618
[TBL] [Abstract][Full Text] [Related]
64. Recent advances in topical delivery of proteins and peptides mediated by soft matter nanocarriers.
Witting M; Obst K; Friess W; Hedtrich S
Biotechnol Adv; 2015 Nov; 33(6 Pt 3):1355-69. PubMed ID: 25687276
[TBL] [Abstract][Full Text] [Related]
65. Melatonin-Loaded Nanocarriers: New Horizons for Therapeutic Applications.
Chuffa LGA; Seiva FRF; Novais AA; Simão VA; Martín Giménez VM; Manucha W; Zuccari DAPC; Reiter RJ
Molecules; 2021 Jun; 26(12):. PubMed ID: 34200947
[TBL] [Abstract][Full Text] [Related]
66. Immunostimulatory colloidal delivery systems for cancer vaccines.
Saupe A; McBurney W; Rades T; Hook S
Expert Opin Drug Deliv; 2006 May; 3(3):345-54. PubMed ID: 16640495
[TBL] [Abstract][Full Text] [Related]
67. Prevention of microbial biofilms - the contribution of micro and nanostructured materials.
Grumezescu AM; Chifiriuc CM
Curr Med Chem; 2014; 21(29):3311. PubMed ID: 24606506
[TBL] [Abstract][Full Text] [Related]
68. Translatable High Drug Loading Drug Delivery Systems Based on Biocompatible Polymer Nanocarriers.
Chen W; Zhou S; Ge L; Wu W; Jiang X
Biomacromolecules; 2018 Jun; 19(6):1732-1745. PubMed ID: 29690764
[TBL] [Abstract][Full Text] [Related]
69. Recent Developments in the Area of Click-Crosslinked Nanocarriers for Drug Delivery.
Dai Y; Chen X; Zhang X
Macromol Rapid Commun; 2019 Feb; 40(3):e1800541. PubMed ID: 30417477
[TBL] [Abstract][Full Text] [Related]
70. Nanostructured lipid carriers and their current application in targeted drug delivery.
Jaiswal P; Gidwani B; Vyas A
Artif Cells Nanomed Biotechnol; 2016; 44(1):27-40. PubMed ID: 24813223
[TBL] [Abstract][Full Text] [Related]
71. A Comprehensive Review on Role of Nanoparticles in Therapeutic Delivery of Medicine.
Rathor S; Bhatt DC; Aamir S; Singh SK; Kumar V
Pharm Nanotechnol; 2017; 5(4):263-275. PubMed ID: 29141578
[TBL] [Abstract][Full Text] [Related]
72. Drug delivery systems based on nucleic acid nanostructures.
de Vries JW; Zhang F; Herrmann A
J Control Release; 2013 Dec; 172(2):467-83. PubMed ID: 23742878
[TBL] [Abstract][Full Text] [Related]
73. Nanostructuring molecular materials as particles and vesicles for drug delivery, using compressed and supercritical fluids.
Elizondo E; Veciana J; Ventosa N
Nanomedicine (Lond); 2012 Sep; 7(9):1391-408. PubMed ID: 22994957
[TBL] [Abstract][Full Text] [Related]
74. Nanostructured lipid (NLCs) carriers as a bioavailability enhancement tool for oral administration.
Gaba B; Fazil M; Ali A; Baboota S; Sahni JK; Ali J
Drug Deliv; 2015; 22(6):691-700. PubMed ID: 24670099
[TBL] [Abstract][Full Text] [Related]
75. [Inhalative pharmacotherapy in the future--nanocarriers for pulmonary drug delivery].
Gessler T
Pneumologie; 2009 Dec; 63 Suppl 2():S113-6. PubMed ID: 20013540
[TBL] [Abstract][Full Text] [Related]
76. Recent trends of nanomedicinal approaches in clinics.
Dilnawaz F; Acharya S; Sahoo SK
Int J Pharm; 2018 Mar; 538(1-2):263-278. PubMed ID: 29339248
[TBL] [Abstract][Full Text] [Related]
77. Capsid-like supramolecular dendritic systems as pH-responsive nanocarriers for drug penetration and site-specific delivery.
Li Y; Lai Y; Xu X; Zhang X; Wu Y; Hu C; Gu Z
Nanomedicine; 2016 Feb; 12(2):355-64. PubMed ID: 26711961
[TBL] [Abstract][Full Text] [Related]
78. PEGylated nanocarriers: A promising tool for targeted delivery to the brain.
Gajbhiye KR; Pawar A; Mahadik KR; Gajbhiye V
Colloids Surf B Biointerfaces; 2020 Mar; 187():110770. PubMed ID: 31926790
[TBL] [Abstract][Full Text] [Related]
79. Stability of nanosuspensions in drug delivery.
Wang Y; Zheng Y; Zhang L; Wang Q; Zhang D
J Control Release; 2013 Dec; 172(3):1126-41. PubMed ID: 23954372
[TBL] [Abstract][Full Text] [Related]
80. Therapeutic applications of nanobiotechnology.
Dutt Y; Pandey RP; Dutt M; Gupta A; Vibhuti A; Vidic J; Raj VS; Chang CM; Priyadarshini A
J Nanobiotechnology; 2023 May; 21(1):148. PubMed ID: 37149615
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
